New Funding Boosts Research into Cluster Headache at Karolinska Institutet

Region Stockholm has awarded a SEK 1.1 million grant to researchers at Karolinska Institutet and Karolinska University Hospital to support advanced research into cluster headache. The three-year project, running from 2026-2028, aims to improve diagnosis and treatment for this often-misdiagnosed and debilitating neurological condition.

Understanding Cluster Headache

Cluster headache is a severe neurological condition characterized by intense pain, often described as piercing or burning, typically located around one eye. It’s associated with a significant disease burden and an increased risk of mental health issues [1]. The condition is frequently underdiagnosed or misdiagnosed, highlighting the need for improved diagnostic tools and treatment strategies.

The Research Project: A Multifaceted Approach

The funded project, titled “Mapping of cluster headache with a focus on heredity, sex, sleep and circadian rhythm for more effective diagnosis and treatment,” will employ a comprehensive approach. Researchers will combine genetic studies with investigations into sleep and circadian rhythms to gain a deeper understanding of the underlying mechanisms of cluster headache. This research builds upon the team’s existing work, having already established the world’s largest biobank of biological samples and clinical data from cluster headache patients and control participants [1].

Key areas of investigation include:

• Genetic Analysis: Detailed genetic analyses and functional studies of risk genes linked to cluster headaches.
• Patient Characteristics: Systematic studies of patient characteristics, including gender differences, hormonal factors, co-occurring conditions (comorbidity), and mental health.
• Sleep and Circadian Rhythms: Investigation of sleep patterns using questionnaires, nightly sleep recordings, and measurements of daily activity and circadian rhythm.

Towards Precision Medicine

The ultimate goal of this research is to advance the development of precision medicine for cluster headache. This involves identifying biological markers that can categorize patients into subgroups and predict their response to different treatments. Researchers will also evaluate treatment strategies tailored to individual sleep patterns and biological rhythms [1].

Collaboration and Clinical Impact

The research team emphasizes the importance of close collaboration between researchers and neurology clinics. This partnership is expected to accelerate the translation of research findings into clinical practice, leading to faster improvements in patient care. The researchers hope their work will ultimately result in new diagnostic tests, better treatment options, and strategies that address both sleep and mental health aspects of the condition [1].

Andrea Carmine Belin, the researcher leading the project at the Department of Neuroscience, stated that receiving the ALF grant is “an important recognition of my team’s research and established collaboration with skilled clinicians.”